Friday, July 31, 2026

How China’s Solar and EV Technologies Are Reshaping Asia Amid US-Iran Conflict

Asian nations aligning with China thrive amid U.S.-Iran conflict, while U.S. allies struggle with rising oil prices and geopolitical shifts.

President Yoon Hits Pause on Domestic Issues for Czech Republic Visit

South Korean President Yoon Suk Yeol is officially visiting the Czech Republic, temporarily setting aside pressing domestic issues.

Tired All the Time? Your Lethargy Might Be More Serious Than You Think

Myasthenia gravis is an autoimmune disorder causing muscle weakness and fatigue, requiring careful diagnosis and lifelong treatment.

Tag: FDA approval

GC Biopharma Targets Full Utilization of Plasma Centers with FDA Approval of ABO Plasma

GC Biopharma's ABO Plasma gains FDA approval for its Laredo center, enhancing plasma sourcing and operational efficiency ahead of schedule.

Samsung Bioepis Secures U.S. Approval for Pen-Style Stelara Biosimilar, Setting a Market First

Samsung Bioepis receives FDA approval for Epyztek, the first pre-filled pen for autoimmune treatments, enhancing patient convenience.

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

J&J Aims to Treat Cancer Before It Starts Showing Symptoms

Johnson & Johnson leads in multiple myeloma treatment, pioneering early intervention for high-risk patients with a new subcutaneous formulation.

Novo Nordisk Pushes for First Oral Obesity Drug Approval

Novo Nordisk seeks FDA approval for oral Wegovy, potentially the first oral obesity treatment, amid competition with Eli Lilly.

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

FDA Greenlights CMG’s Film-Based Schizophrenia Medication ‘Mezofy’

CMG Pharmaceutical gains FDA approval for Mezofy, a unique oral film for schizophrenia, marking a milestone for South Korean pharma.

Top News

- Our Sponsors Ad -

Follow us